feedback

Course Director

Robert Dreicer, MD, MS, MACP, FASCO
Robert Dreicer, MD, MS, MACP, FASCO

University of Virginia Cancer Center
Paul Mellon Urologic Cancer Institute
University of Virginia School of Medicine
Charlottesville, Virginia

Faculty

Michael S. Cookson
Michael S. Cookson, MD, MMHC

The University of Oklahoma Health Sciences Center & The Stephenson Cancer Center
Oklahoma City, Oklahoma

Oliver Sartor
Oliver Sartor, MD

Tulane Cancer Center

Tulane Medical School

New Orleans, Louisiana

Neal D. Shore
Neal D. Shore, MD, FACS

Carolina Urologic Research Center

Atlantic Urology Clinics

Myrtle Beach, South Carolina

Accredited by

Penn State College of Medicine

Activity Details

Credit Types:CME
Credit Amount:1.5 Credits
Release Date:2018-Jun-27
Expiration Date:2019-Jun-26
Estimated Time for Completion:1.5 hour
Registration Required:No
Cost:Free of charge

Activity Description and Educational Objectives

In this activity, a panel of urology and oncology experts combine key clinical evidence and current guideline recommendations with practical instruction for the day-to-day management of early-stage and advanced prostate cancer, and highlight the connection between data and everyday practice via illustrative personal stories of patients with prostate cancer. In addition, the experts offer their perspectives and advice on how to involve patients in their own care to optimally navigate the complex treatment landscape of prostate cancer.

Upon completion of this activity, participants should be better able to:
  • Assess recent clinical evidence on hormone, cytotoxic, immunologic, bone-directed, and other novel therapies and combinations for early-stage and advanced prostate cancer
  • Summarize the latest guidelines and consensus recommendations for selection and sequencing of therapies in the management of patients with early-stage and advanced prostate cancer
  • Develop personalized, evidence-based treatment plans for patients with prostate cancer throughout the disease continuum
  • Provide appropriate disease- and treatment-related education to patients with prostate cancer

Target Audience

This activity has been designed to meet the educational needs of urologists and other clinicians involved in the management of patients with prostate cancer.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: June 27, 2018 - June 26, 2019
Time to Complete: 90 minutes

Faculty and Disclosure / Conflict of Interest Policy

In accordance with ACCME requirements, Penn State College of Medicine has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Course Director and Moderator

Robert Dreicer, MD, MS, MACP, FASCO
Section Head Medical Oncology
Deputy Director, University of Virginia Cancer Center
Associate Director for Clinical Research
Co-Director, Paul Mellon Urologic Cancer Institute
Professor of Medicine and Urology
University of Virginia School of Medicine
Charlottesville, Virginia

Robert Dreicer, MD, MS, MACP, FASCO, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Astellas Pharma US, Inc.; AstraZeneca; Bristol-Myers Squibb; EMD Serono, Inc.; Genentech, Inc.; Incyte Corporation; Orion; and Pfizer Inc.

Faculty

Michael S. Cookson, MD, MMHC
Professor & Chair
Department of Urology
Donald D. Albers Chair in Urology
The University of Oklahoma Health Sciences Center & The Stephenson Cancer Center
Oklahoma City, Oklahoma

Michael S. Cookson, MD, MMHC, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Bayer HealthCare Pharmaceuticals, Inc.; Janssen Pharmaceuticals, Inc.; MDxHealth; Myovant Sciences Ltd.; Precision Biopsy, LLC.; and TesoRx Pharma, LLC.

Oliver Sartor, MD
Medical Director, Tulane Cancer Center
Assistant Dean for Oncology
Tulane Medical School
New Orleans, Louisiana

Oliver Sartor, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for Advanced Accelerator Application (AAA); AstraZeneca; Bavarian Nordic; Bayer Corporation; Bellicum Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Celgene Corporation; Constellation Pharmaceuticals; Dendreon, Inc.; EMD Serono, Inc.; Endocyte; Johnson & Johnson Services, Inc.; OncoGenex Pharmaceuticals Inc.; Pfizer Inc.; and sanofi-aventis U.S. LLC.
Grant/Research Support from Bayer Corporation; Endocyte; Innocrin Pharmaceuticals Inc.; Johnson & Johnson Services, Inc.; Merck & Co., Inc.; and sanofi-aventis U.S. LLC.
Other Financial or Material Support from GU Committee where he serves as co-chairman.

Neal D. Shore, MD, FACS
Director, CPI, Carolina Urologic Research Center
Atlantic Urology Clinics
Myrtle Beach, South Carolina

Neal D. Shore, MD, FACS, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for AbbVie Inc.; Amgen Inc.; AstraZeneca; Bayer Corporation; Bristol-Myers Squibb Company; Dendreon Pharmaceuticals LLC; Ferring Pharmaceuticals; Innocrin Pharmaceuticals Inc.; InVivo Therapeutics; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; Pfizer Inc.; sanofi-aventis U.S. LLC/Genzyme Corporation; and Tolmar Pharmaceuticals, Inc.
Grant/Research Support from AbbVie Inc.; Amgen Inc.; AstraZeneca; Bayer Corporation; Bristol-Myers Squibb Company; Dendreon Pharmaceuticals LLC; Ferring Pharmaceuticals; Innocrin Pharmaceuticals Inc.; InVivo Therapeutics; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; Pfizer Inc.; sanofi-aventis U.S. LLC/Genzyme Corporation; and Tolmar Pharmaceuticals, Inc.
Stock Shareholder in AbbVie Inc.; Amgen Inc.; AstraZeneca; Bayer Corporation; Bristol-Myers Squibb Company; Dendreon Pharmaceuticals LLC; Ferring Pharmaceuticals; Innocrin Pharmaceuticals Inc.; InVivo Therapeutics; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; Pfizer Inc.; sanofi-aventis U.S. LLC/Genzyme Corporation; and Tolmar Pharmaceuticals, Inc.
Other Financial or Material Support from AbbVie Inc.; Amgen Inc.; AstraZeneca; Bayer Corporation; Bristol-Myers Squibb Company; Dendreon Pharmaceuticals LLC; Ferring Pharmaceuticals; Innocrin Pharmaceuticals Inc.; InVivo Therapeutics; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; Pfizer Inc.; sanofi-aventis U.S. LLC/Genzyme Corporation; and Tolmar Pharmaceuticals, Inc. in the form of employment affiliations, royalties, and patents.

Medical Director

Aarati Ranganathan, PhD
PVI, PeerView Institute for Medical Education

Aarati Ranganathan, PhD, has no financial interests/relationships or affiliations in relation to this activity.

Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.

Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.

Providership, Credit, and Support

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and PVI, PeerView Institute for Medical Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Penn State College of Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Information about CME credit for this activity is available by contacting Penn State at 717-531-6483 or ContinuingEd@hmc.psu.edu. Reference course # G6277-19-T.

Providership


This CME activity is jointly provided by Penn State College of Medicine and PVI, PeerView Institute for Medical Education.

Support

This activity is supported by independent educational grants from AbbVie, Astellas and Medivation, Inc., a Pfizer Company., Bayer HealthCare Pharmaceuticals Inc., Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, and Sanofi Genzyme.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. For approved prescribing information, please consult the manufacturer’s product labeling.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView or any of its partners, providers, and/or supporters.

About This CME Activity

PVI, PeerView Institute for Medical Education, and Penn State College of Medicine are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of PeerView activities is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of PVI and Penn State College of Medicine.

Copyright © 2000-2018, PeerView

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.